Author name: Leonardo Arias

CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott Investment Management.

The small molecule, vatiquinone, had already flunked a Phase III trial, but the company pushed ahead with an approval bid anyway.

A new study in JAMA contradicts a series of statements made by HHS Secretary Robert F. Kennedy Jr. that paint vaccine advisory committees at the CDC and FDA as hopelessly corrupt.

The average wage of chief executives rose by 27.5% from 2009 to 2023, while the average pay for all hospital employees rose 9.8%, according to research in Health Affairs.

Viking Therapeutics’ VK2735 achieves a 10.9% placebo-adjusted weight loss at 13 weeks, but a less than ideal safety profile marred the results.

Adaptive and Genentech first partnered in 2018 to advance T cell receptor-based therapies for cancer.

The FDA has postponed its decision date for Regenxbio’s Hunter syndrome gene therapy to review additional longer-term clinical data for the asset.

While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured investors it has the manufacturing capacity to roll out oral semaglutide without restrictions on supply.

VantAI will use its machine learning capabilities to identify novel target-effector pairs that Halda can use in designing its bifunctional small-molecule drugs.

Para tratar las infecciones bacterianas, se usan antibióticos. Pero el organismo no utiliza toda la cantidad de medicamento. Una parte acaba en las aguas residuales, donde pueden desarrollarse bacterias resistentes a los antibióticos. Ahora, a fin de conseguir un tratamiento antibi&oac …